本文应用溴隐亭(bromocriptine)治疗11例垂体生长素(GH)瘤患者,报告如下。 病例资料 11例患者(男7例,女4例),年龄25～51岁,平均41岁,随访观察溴隐亭服药时间9～21个月,平均17个月。其中9例是经本院脑外科手术切除GH瘤后复发患者。术后病程在1～6年内复发。9例中4例术后放射 This article uses bromocriptine to treat 11 cases of pituitary auxin (GH) tumors. The report is as follows. Case data 11 patients (male 7 and female 4), aged 25 to 51 years old, average 41 years old, follow-up bromocriptine medication time 9 to 21 months, an average of 17 months. Nine of them were relapsed patients who had undergone brain surgery to remove GH tumors. The course of the disease recurs within 1 to 6 years. 4 cases of postoperative radiation in 9 cases